Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas

CARY, N.C., Sept. 2, 2024 /PRNewswire/ — On 28 May 2024, Asahi Kasei Corporation (“Asahi Kasei”) announced a recommended public offer (the “Offer”) to acquire all shares and American Depositary Shares (“ADSs”) in Calliditas Therapeutics AB (publ) (“Calliditas”). The Offer consists of a…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.